
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Tetralogy of Fallot
Introduction
For patient information, click here Template:DiseaseDisorder infobox
Overview
Overview
Tetralogy of Fallot was first discovered by Etienne Fallot, a French ohysician in 1888. Tetralogy of Fallot is a congenital heart defect which classically has four anatomical components: obstruction to right ventricular outflow, right ventricular hypertrophy, ventricular septal defect, and overriding of aorta. It accounts for approximately 10% of all forms of congenital heart disease. It is the most common cause of cyanosis in children over one year of age (blue baby syndrome). It is understood that tetralogy of fallot is the result of improper positioning of the outlet septum. In the normal heart, the outlet septum is an indistinguishable component of the crista supraventricularis that communicates with the septomarginal trabeculae to divide the right and left ventricular cavities. In Tetralogy of Fallot, proper ventricular septation is perturbed by anterocephalad displacement of the outlet septum relative to the septomarginal trabecula. These features include a ventricular septal defect, overriding aorta, pulmonary stenosis, and right ventricular hypertrophy. The obstruction of right ventricular outflow in tetralogy of Fallot causes blood to shunt or flow from the right to left side of heart through the ventricular septal defect. This causes right ventricular hypertrophy and eventual right sided heart failure. There is flow of deoxygenated venous blood from the right side of the heart to the systemic circulation resulting in cyanosis. Common causes of tetralogy of Fallot may include: Alcoholism in the mother, diabetes, pregnancy after the age of 40, rubella or other viral illnesses during pregnancy, phenylketonuria (PKU) in the mother, fetal hydantoin syndrome, and fetal carbamazepine syndrome. On the basis cyanosis, tetralogy of Fallot must be differentiated from total anomalous pulmonary venous connection, tricuspid atresia, transposition of the great vessels, and truncus arteriosus. Tetralogy of Fallot occurs in approximately 30 to 60 per 100,000 births. Tetralogy of Fallot represents 5-7% of congenital heart defects. The majority of cases are thought to be sporadic and are not familial. Tetralogy of Fallot occurs slightly more often in males than in females. Common risk factors in the development of tetralogy of Fallot include: Alcoholism in the mother, diabetes, and pregnancy after the age of 40. According to the Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association, screening for tetralogy of Fallot by pulse oxymetry is recommended for all newborns. The prognosis of patients with repaired tetralogy of Fallot has improved over the years and these patients now have the potential to lead normal lives. As these patients grow, there may be leakage of the repaired pulmonic valve. There may be a persistent risk of sudden cardiac death. Echocardiography is the gold standard test for the diagnosis of tetralogy of fallot. Echocardiography establishes the initial diagnosis of tetralogy of Fallot, and is useful in evaluating the hemodynamic abnormalities that are present. Right-to-left shunting through the VSD can be visualized by color doppler imaging, and the severity of right ventricular outflow tract obstruction can be determined by spectral doppler measurements. Echocardiography may be helpful in the diagnosis of tetralogy of fallot. Findings on an echocardiography diagnostic of tetralogy of fallot include ventricular septal defect, right ventricular outflow tract obstruction, and overriding aorta. Repair of tetralogy of Fallot reduces mortality. we can either perform palliative surgery which involves forming an anastomosis between the subclavian artery and the pulmonary artery. This redirected a large portion of the partially oxygenated blood leaving the heart for the body into the lungs, increasing flow through the pulmonary circuit, and greatly relieving symptoms in patients or total surgical repair which involves making incisions into the heart muscle, relieving the right ventricular outflow tract stenosis by careful resection of muscle, repairing the VSD using a Gore-Tex or Dacron patch or a homograft. Additional reparative or reconstructive work may be done on patients as required by their particular anatomy.The repair could be done by either of the approaches i.e.transatrial or transpulmonary.
Historical Perspective
Tetralogy of Fallot was first discovered by Etienne Fallot, a French ohysician in 1888.
Classification
There is no established system for the classification of tetralogy of Fallot.
Pathophysiology
Tetralogy of Fallot is a congenital heart lesion characterized by a constellation of four morphologic abnormalities present in the newborn heart. It is understood that tetralogy of fallot is the result of improper positioning of the outlet septum. In the normal heart, the outlet septum is an indistinguishable component of the crista supraventricularis that communicates with the septomarginal trabeculae to divide the right and left ventricular cavities. In Tetralogy of Fallot, proper ventricular septation is perturbed by anterocephalad displacement of the outlet septum relative to the septomarginal trabecula. These features include a ventricular septal defect, overriding aorta, pulmonary stenosis, and right ventricular hypertrophy. The obstruction of right ventricular outflow in tetralogy of Fallot causes blood to shunt or flow from the right to left side of heart through the ventricular septal defect. This causes right ventricular hypertrophy and eventual right sided heart failure. There is flow of deoxygenated venous blood from the right side of the heart to the systemic circulation resulting in cyanosis.
Causes
Common causes of tetralogy of Fallot may include: Alcoholism in the mother, diabetes, pregnancy after the age of 40, rubella or other viral illnesses during pregnancy, phenylketonuria (PKU) in the mother, fetal hydantoin syndrome, and fetal carbamazepine syndrome.
Differentiating Tetralogy of Fallot from other Diseases
On the basis cyanosis, tetralogy of Fallot must be differentiated from total anomalous pulmonary venous connection, tricuspid atresia, transposition of the great vessels, and truncus arteriosus.
Epidemiology and Demographics
Tetralogy of Fallot occurs in approximately 30 to 60 per 100,000 births. Tetralogy of Fallot represents 5-7% of congenital heart defects. The majority of cases are thought to be sporadic and are not familial. Tetralogy of Fallot occurs slightly more often in males than in females.
Risk factors
Common risk factors in the development of tetralogy of Fallot include: Alcoholism in the mother, diabetes, and pregnancy after the age of 40.
Screening
According to the Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association, screening for tetralogy of Fallot by pulse oxymetry is recommended for all newborns.
Natural History, Complications and Prognosis
The prognosis of patients with repaired tetralogy of Fallot has improved over the years and these patients now have the potential to lead normal lives. As these patients grow, there may be leakage of the repaired pulmonic valve. There may be a persistent risk of sudden cardiac death.
Diagnosis
Diagnostic Study of Choice
Echocardiography is the gold standard test for the diagnosis of tetralogy of fallot.
History and Symptoms
Patients with tetralogy of Fallot may have a positive history of alcoholism, diabetes, Poor nutrition in mother in mother. Common symptoms of tetralogy of Fallot include sudden, marked bluish skin (tet spell), dyspnea on exertion, difficulty in feeding, failure to gain weight, failure to thrive, retarded growth and physical development, and hemoptysis.
Physical Examination
Patients with tetralogy of Fallot usually appear small due to a failure to thrive. Physical examination of patients with tetralogy of Fallot is usually remarkable for cyanosis, systolic thrill, systolic ejection murmur, and Clubbing.
Laboratory Findings
Laboratory findings consistent with the diagnosis of tetralogy of fallot include diminished oxygen saturation, hematocrit between 65% to 70%, and low platelet count and coagulation factors.
Electrocardiogram
An ECG may be helpful in the diagnosis of tetralogy of Fallot. Findings on an ECG suggestive of tetralogy of Fallot include right axis deviation, right ventricular hypertrophy, wide QRS, and right bundle branch block.
X Ray
An x-ray may be helpful in the diagnosis of tetralogy of fallot. Findings on an x-ray diagnostic of tetralogy of fallot include normal or decreased pulmonary vascularity, concave pulmonary artery segment, “boot-like” heart, and right sided aortic arch.
Echocardiography
Echocardiography establishes the initial diagnosis of tetralogy of Fallot, and is useful in evaluating the hemodynamic abnormalities that are present. Right-to-left shunting through the VSD can be visualized by color doppler imaging, and the severity of right ventricular outflow tract obstruction can be determined by spectral doppler measurements. Echocardiography may be helpful in the diagnosis of tetralogy of fallot. Findings on an echocardiography diagnostic of tetralogy of fallot include ventricular septal defect, right ventricular outflow tract obstruction, and overriding aorta.
CT
Computed tomography can be helpful as a diagnostic tool in conditions where the echocardiographic findings are inconclusive.
MRI
Magnetic resonance imaging can be helpful as a diagnostic tool in patients in whom the echocardiographic findings are inconclusive.
Other Imaging Findings
There are no other imaging findings associated with tetralogy of fallot.
Other Diagnostic Studies
There are no other diagnostic studies associated with tetralogy of fallot.
Treatment
Medical Therapy
Although operative repair of tetralogy of Fallot is definitive, medical therapy can be used to manage hypoxic or tet spells. Tet spells cause acute hypoxia and may be treated with beta blockers, morphine, phenylephrine, and oxygen.
Surgery
Repair of tetralogy of Fallot reduces mortality. we can either perform palliative surgery which involves forming an anastomosis between the subclavian artery and the pulmonary artery. This redirected a large portion of the partially oxygenated blood leaving the heart for the body into the lungs, increasing flow through the pulmonary circuit, and greatly relieving symptoms in patients or total surgical repair which involves making incisions into the heart muscle, relieving the right ventricular outflow tract stenosis by careful resection of muscle, repairing the VSD using a Gore-Tex or Dacron patch or a homograft. Additional reparative or reconstructive work may be done on patients as required by their particular anatomy.The repair could be done by either of the approaches i.e.transatrial or transpulmonary.
Primary Prevention
There are no established measures for the primary prevention of Tetralogy of Fallot.
Secondary Prevention
According to the Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association, screening for tetralogy of Fallot by pulse oxymetry is recommended for all newborns.
References
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Fahimeh Shojaei, M.D., Priyamvada Singh, M.B.B.S. [2],Kristin Feeney, B.S. [3]
Historical Perspective
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Overview
Tetralogy of Fallot was first discovered by Etienne Fallot, a French ohysician in 1888.
Historical Perspective
Discovery
- Tetralogy of Fallot was first discovered by Etienne Fallot, a French ohysician in 1888.[1][2][3]
- Many physicians had described morphologic anomalies of heart related to tetralogy of fallot such as:
- Niels Stensen (1671)
- Eduard Sandifort (1777)
- William Hunter (1784)
- J. P. Farre (1814)
- Thomas Bevill Peacock (1846)
- Thomas Bevill Peacockβs (1866)
References
- β Evans, William N. (2008). ““Tetralogy of Fallot” and Γtienne-Louis Arthur Fallot”. Pediatric Cardiology. 29 (3): 637β640. doi:10.1007/s00246-007-9186-8. ISSNΒ 0172-0643.
- β Tubbs, R. Shane; Gianaris, Nicholas; Shoja, Mohammadali M.; Loukas, Marios; Cohen Gadol, Aaron A. (2012). “?The heart is simply a muscle? and first description of the tetralogy of ?Fallot?. Early contributions to cardiac anatomy and pathology by bishop and anatomist Niels Stensen (1638?1686)”. International Journal of Cardiology. 154 (3): 312β315. doi:10.1016/j.ijcard.2010.09.055. ISSNΒ 0167-5273.
- β Neill CA, Clark EB (1994). “Tetralogy of Fallot. The first 300 years”. Tex Heart Inst J. 21 (4): 272β9. PMIDΒ 7888802.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Fahimeh Shojaei, M.D., Priyamvada Singh, M.B.B.S. [2], Kristin Feeney, B.S. [3]
Classification
Overview
There is no established system for the classification of tetralogy of Fallot.
Classification
There is no established system for the classification of tetralogy of Fallot.
References
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Pathophysiology
Overview
Tetralogy of Fallot is a congenital heart lesion characterized by a constellation of four morphologic abnormalities present in the newborn heart. It is understood that tetralogy of fallot is the result of improper positioning of the outlet septum. In the normal heart, the outlet septum is an indistinguishable component of the crista supraventricularis that communicates with the septomarginal trabeculae to divide the right and left ventricular cavities. In Tetralogy of Fallot, proper ventricular septation is perturbed by anterocephalad displacement of the outlet septum relative to the septomarginal trabecula. These features include a ventricular septal defect, overriding aorta, pulmonary stenosis, and right ventricular hypertrophy. The obstruction of right ventricular outflow in tetralogy of Fallot causes blood to shunt or flow from the right to left side of heart through the ventricular septal defect. This causes right ventricular hypertrophy and eventual right sided heart failure. There is flow of deoxygenated venous blood from the right side of the heart to the systemic circulation resulting in cyanosis.
Pathophysiology
Physiology
The normal physiology of heart development can be understood as follows:
- Subsequent to the lateral folding and looping events that give rise to the primitive heart tube are a series of complex septation processes that will ultimately complete morphogenesis of the four chambered heart.
- The goals of cardiac septation are two-fold:
- To create four distinct cardiac chambers
- To correctly position the great vessels relative to these chambers

Pathogenesis
- It is understood that tetralogy of fallot is the result of improper positioning of the outlet septum.[1][2][3]
- In the normal heart, the outlet septum is an indistinguishable component of the crista supraventricularis that communicates with the septomarginal trabeculae to divide the right and left ventricular cavities.
- In Tetralogy of Fallot, proper ventricular septation is perturbed by anterocephalad displacement of the outlet septum relative to the septomarginal trabecula.
- The direct consequence of this misalignment is an overriding aortic orifice and a ventricular septal defect, resulting in an intracardiac right to left shunt of blood.
- In addition, anterocephalad displacement of the outlet septum indirectly predisposes the pulmonary trunk to stenosis in the setting of septoparietal trabecular hypertrophy.
- Together, the displacement of the outlet septum coupled with the hypertrophic arrangement of the septoparietal trabeculae account for the three anatomical cardinal defects in Tetralogy of Fallot – aortic dextroposition, interventricular communication (VSD), and pulmonary stenosis.
- The fourth defect – right ventricular hypertrophy – is a hemodynamic consequence of these three morphologic changes, as the right ventricle physiologically adapts to the increased resistance of a stenotic pulmonary trunk.

Anatomy
![]()
{{#ev:youtube|ACRfFkxow7w}} |
Embrylogy
- Embryologic studies show that tetralogy of Fallot is a result of anterior misalignment of the conal septum, resulting in the clinical combination of a ventricular septal defect (VSD), pulmonary stenosis, and an overriding aorta.
- Right ventricular hypertrophy is secondary to this combination of abnormalities, which causes resistance to blood flow from the right ventricle.
- Tetralogy of Fallot results in cyanosis, (hypoxia or low oxygenation) of the blood due to mixing of deoxygenated venous blood from the right ventricle with oxygenated blood in the left ventricle through the ventricular septal defect and preferential flow of both oxygenated and deoxygenated blood from the ventricles through the aorta because of obstruction to flow through the pulmonary valve.
- This is known as a right-to-left shunt.
- If pulmonary blood flow is dramatically reduced, pulmonary blood flow may depend on a patent ductus arteriosus (PDA) or bronchial collaterals.
- If obstruction of the right ventricular outflow tract is minimal, the intracardiac shunt may be mostly from left to right, and this may result in what is termed a pink tet or pink tetralogy.
- Although cyanosis is absent on clinical exam, laboratory testing will often show systemic oxygen desaturation.
- Children with tetralogy of Fallot may develop acute severe cyanosis or hypoxic tet spells.
- The mechanism underlying these episodes is not entirely clear, but may be due to spasm of the infundibular septum and the right ventricular outflow tract.
- Whatever the mechanism, there is an increase in resistance to blood flow to the lungs with increased preferential flow of desaturated blood to the systemic circulation.
- The child will often squat during a tet spell to improve venous return to the right side of the heart.
- Squatting increases the systemic vascular resistance and thereby shunts flow to pulmonary circuit.
- These spells can be fatal, and can occur in patients who are not cyanotic.
Genetics
- Genes involved in the pathogenesis of tetralogy of fallot include:[8][9][10][11][12][13][14]
- The cellular processes that underlie cardiogenesis are extensively regulated in the developing heart.
- Proper cardiac development requires the complex orchestration of cardiac transcription factors and signaling pathways in a spatiotemporal specific manner.
- Previous genetic studies demonstrated that mutations in numerous genes encoding cardiac transcription factors and cell signaling proteins have a role in the development of Tetralogy of Fallot.
- Specifically, heterozygous mutations in NKX2-5, HAND1, TBX5, and GATA4 have been reported in familial forms of disease.
- Many of these single gene mutations result in haploinsufficiency and suggest a dose dependent relationship between genetic expression and disease.
- While the mechanistic basis of this relationship is currently poorly understood, it is hypothesized that disruption of the direct protein–protein interactions that allow these transcription factors to work synergistically impedes the activation of downstream targets and signaling pathways central to cardiac morphogenesis.
- In addition, recent whole-exome sequencing investigations have introduced a novel role for epigenetic dysregulation in the pathogenesis of Tetralogy of Fallot.
- Aberrant epigenetic modifications are thought to provide an alternative mechanism to perturb normal spatiotemporal expression of these essential developmental genes.
Associated Conditions
- Conditions associated with tetralogy of fallot include:[15][16][17][18]
- Left superior vena cava
- Anomalies of the mitral valve
- Anomalies of the tricuspid valve
- Stenosis of the left pulmonary artery, in 40% of patients
- A bicuspid pulmonary valve, in 40% of patients
- Right sided aortic arch, in 25% of patients
- Coronary artery anomalies, in 10% of patients
- An atrial septal defect, in which case the syndrome is sometimes called a pentalogy of Fallot.
- An atrioventricular septal defect
- Partially or totally anomalous pulmonary venous return
- Forked ribs and scoliosis
- Associated abnormalities include cleft lip, cleft palate, hypospadias, skeletal and craniofacial abnormalities.
Gross Pathology
- On gross pathology characteristic features findings of tetralogy of fallot include:
- Right ventricular hypertrophy
- VSD
- Overriding aorta
- Subpulmonic stenosis

Microscopic Pathology
There is no characteristic findings of tetralogy of fallot on microscopic histopathological analysis.
References
- β Anderson RH, Jacobs ML (2008). “The anatomy of tetralogy of Fallot with pulmonary stenosis”. Cardiol Young. 18 Suppl 3: 12β21. doi:10.1017/S1047951108003259. PMIDΒ 19094375.
- β Bashore TM (2007). “Adult congenital heart disease: right ventricular outflow tract lesions”. Circulation. 115 (14): 1933β47. doi:10.1161/CIRCULATIONAHA.105.592345. PMIDΒ 17420363.
- β Bailliard F, Anderson RH (2009). “Tetralogy of Fallot”. Orphanet J Rare Dis. 4: 2. doi:10.1186/1750-1172-4-2. PMCΒ 2651859. PMIDΒ 19144126.
- β 4.0 4.1 4.2 Gatzoulis MA, Webb GD, Daubeney PE. (2005) Diagnosis and Management of Adult Congenital Heart Disease. Churchill Livingstone, Philadelphia. ISBN 0443071039.
- β Bartelings M, Gittenberger-de Groot A (1991). “Morphogenetic considerations on congenital malformations of the outflow tract. Part 1: Common arterial trunk and tetralogy of Fallot”. Int. J. Cardiol. 32 (2): 213β30. PMIDΒ 1917172.
- β Anderson RH, Weinberg. The clinical anatomy of tetralogy of Fallot. Cardiol Young. 2005 15;38-47. PMID 15934690.
- β Anderson RH, Tynan M. Tetralogy of Fallot β a centennial review. Int J Cardiol. 1988 21; 219-232. PMID 3068155.
- β Olson EN (2006). “Gene regulatory networks in the evolution and development of the heart”. Science. 313 (5795): 1922β7. doi:10.1126/science.1132292. PMIDΒ 17008524.
- β Yang YQ, Gharibeh L, Li RG, Xin YF, Wang J, Liu ZM; et al. (2013). “GATA4 loss-of-function mutations underlie familial tetralogy of fallot”. Hum Mutat. 34 (12): 1662β71. doi:10.1002/humu.22434. PMIDΒ 24000169.
- β Bruneau BG (2008). “The developmental genetics of congenital heart disease”. Nature. 451 (7181): 943β8. doi:10.1038/nature06801. PMIDΒ 18288184.
- β Bruneau BG, Srivastava D (2014). “Congenital heart disease: entering a new era of human genetics”. Circ Res. 114 (4): 598β9. doi:10.1161/CIRCRESAHA.113.303060. PMIDΒ 24526674.
- β Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R; et al. (2001). “Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation”. Nat Genet. 28 (3): 276β80. doi:10.1038/90123. PMIDΒ 11431700.
- β Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA; et al. (2003). “GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5”. Nature. 424 (6947): 443β7. doi:10.1038/nature01827. PMIDΒ 12845333.
- β Sheng W, Qian Y, Wang H, Ma X, Zhang P, Diao L; et al. (2013). “DNA methylation status of NKX2-5, GATA4 and HAND1 in patients with tetralogy of fallot”. BMC Med Genomics. 6: 46. doi:10.1186/1755-8794-6-46. PMCΒ 3819647. PMIDΒ 24182332.
- β Dabizzi RP, Caprioli G, Aiazzi L, Castelli C, Baldrighi G, Parenzan L, Baldrighi V (January 1980). “Distribution and anomalies of coronary arteries in tetralogy of fallot”. Circulation. 61 (1): 95β102. doi:10.1161/01.cir.61.1.95. PMIDΒ 7349946.
- β Satyanarayana Rao, B.N.; Anderson, Ray C.; Edwards, Jesse E. (1971). “Anatomic variations in the tetralogy of Fallot”. American Heart Journal. 81 (3): 361β371. doi:10.1016/0002-8703(71)90106-2. ISSNΒ 0002-8703.
- β Muster, Alexander J.; Paul, Milton H.; Nikaidoh, Hisashi (1973). “Tetralogy of Fallot Associated with Total Anomalous Pulmonary Venous Drainage”. Chest. 64 (3): 323β326. doi:10.1378/chest.64.3.323. ISSNΒ 0012-3692.
- β Saifi, Comron; Matsumoto, Hiroko; Vitale, Michael G.; Roye, David P.; Hyman, Joshua E. (2012). “The incidence of congenital scoliosis in infants with tetralogy of Fallot based on chest radiographs”. Journal of Pediatric Orthopaedics B. 21 (4): 313β316. doi:10.1097/BPB.0b013e3283536872. ISSNΒ 1060-152X.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Fahimeh Shojaei, M.D., Priyamvada Singh, M.B.B.S. [2], Keri Shafer, M.D. [3]; Omar Toubat; Kristin Feeney, B.S. [4]
Causes
Overview
Common causes of tetralogy of Fallot may include: Alcoholism in the mother, diabetes, pregnancy after the age of 40, rubella or other viral illnesses during pregnancy, phenylketonuria (PKU) in the mother, fetal hydantoin syndrome, and fetal carbamazepine syndrome.
Causes
Common Causes
Common causes of tetralogy of Fallot may include:
- Alcoholism in the mother
- Diabetes
- Pregnancy after the age of 40
- Rubella or other viral illnesses during pregnancy
- Phenylketonuria (PKU) in the mother
- Fetal hydantoin syndrome
- Fetal carbamazepine syndrome
Less Common Causes
Less common causes of tetralogy of Fallot may include:
- Clomifene
- Poor nutrition during pregnancy
Genetic Causes
Genetic causes of tetralogy of Fallot may include:
- There is a high incidence of chromosomal disorders in children with tetralogy of Fallot.[1][2]
- Tetralogy of Fallot is associated with:
- Down syndrome
- DiGeorge syndrome (a 22q11.2 deletion, a condition associated with heart defects, hypocalcemia, and immune deficiency) A gene polymorphism at the methylenetetrahydrofolate reductase (MTHFR) region has been associated with tetralogy of Fallot.
References
- β Marinho C, Alho I, Guerra A, Rego C, Areias J, Bicho M. The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of Fallot. Rev Port Cardiol. Jul-Aug 2009;28(7-8):809-12.
- β Lee CN, Su YN, Cheng WF, Lin MT, Wang JK, Wu MH, et al. Association of the C677T methylenetetrahydrofolate reductase mutation with congenital heart diseases. Acta Obstet Gynecol Scand. Dec 2005;84(12):1134-40.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Fahimeh Shojaei, M.D., Priyamvada Singh, M.B.B.S. [2], Keri Shafer, M.D. [3]; Kristin Feeney, B.S. [4]
Differentiating Tetralogy of Fallot from other Diseases
Overview
On the basis cyanosis, tetralogy of Fallot must be differentiated from total anomalous pulmonary venous connection, tricuspid atresia, transposition of the great vessels, truncus arteriosus.
Differentiating Tetralogy of Fallot from other Diseases
Tetralogy of Fallot must be differentiated from other diseases that cause cyanosis:
References
- β Cherry, James D. (2008). “Croup”. New England Journal of Medicine. 358 (4): 384β391. doi:10.1056/NEJMcp072022. ISSNΒ 0028-4793.
- β Abdallah C (2012). “Acute epiglottitis: Trends, diagnosis and management”. Saudi J Anaesth. 6 (3): 279β81. doi:10.4103/1658-354X.101222. PMCΒ 3498669. PMIDΒ 23162404.
- β Qureshi A, Behzadi A (2008). “Foreign-body aspiration in an adult”. Can J Surg. 51 (3): E69β70. PMCΒ 2496600. PMIDΒ 18682760.
- β Liston SL, Gehrz RC, Siegel LG, Tilelli J (August 1983). “Bacterial tracheitis”. Am. J. Dis. Child. 137 (8): 764β7. PMIDΒ 6869336.
- β Spicuzza L, Caruso D, Di Maria G (2015). “Obstructive sleep apnoea syndrome and its management”. Ther Adv Chronic Dis. 6 (5): 273β85. doi:10.1177/2040622315590318. PMCΒ 4549693. PMIDΒ 26336596.
- β Kim V, Criner GJ (2013). “Chronic bronchitis and chronic obstructive pulmonary disease”. Am J Respir Crit Care Med. 187 (3): 228β37. doi:10.1164/rccm.201210-1843CI. PMCΒ 4951627. PMIDΒ 23204254.
- β Peroni DG, Boner AL (September 2000). “Atelectasis: mechanisms, diagnosis and management”. Paediatr Respir Rev. 1 (3): 274β8. doi:10.1053/prrv.2000.0059. PMIDΒ 12531090.
- β Lee JS, Im JG, Ahn JM, Kim YM, Han MC (August 1992). “Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT”. Radiology. 184 (2): 451β4. doi:10.1148/radiology.184.2.1620846. PMIDΒ 1620846.
- β Simonetti AF, Viasus D, Garcia-Vidal C, CarratalΓ J (2014). “Management of community-acquired pneumonia in older adults”. Ther Adv Infect Dis. 2 (1): 3β16. doi:10.1177/2049936113518041. PMCΒ 4072047. PMIDΒ 25165554.
- β Litonjua AA (June 2009). “Childhood asthma may be a consequence of vitamin D deficiency”. Curr Opin Allergy Clin Immunol. 9 (3): 202β7. doi:10.1097/ACI.0b013e32832b36cd. PMIDΒ 19365260.
- β “Cystic fibrosis – Genetics Home Reference”.
- β Qureshi H, Sharafkhaneh A, Hanania NA (2014). “Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications”. Ther Adv Chronic Dis. 5 (5): 212β27. doi:10.1177/2040622314532862. PMCΒ 4131503. PMIDΒ 25177479.
- β Olalekan, Adebimpe Wasiu; Oluwaseun, Faremi Ayodeji; Oladele, Hassan Abdul-Wasiu; Akeem, Adeyemi Damilare (2015). “Evaluation of electrolyte imbalance among tuberculosis patients receiving treatments in Southwestern Nigeria”. Alexandria Journal of Medicine. 51 (3): 255β260. doi:10.1016/j.ajme.2014.10.003. ISSNΒ 2090-5068.
- β Shaw J, Marshall T, Morris H, Hayton C, Chaudhuri N (2017). “Idiopathic pulmonary fibrosis: a holistic approach to disease management in the antifibrotic age”. J Thorac Dis. 9 (11): 4700β4707. doi:10.21037/jtd.2017.10.111. PMCΒ 5721024. PMIDΒ 29268540.
- β Yen CM, Lin CL, Lin MC, Chen HY, Lu NH, Kao CH (2016). “Pneumoconiosis increases the risk of congestive heart failure: A nationwide population-based cohort study”. Medicine (Baltimore). 95 (25): e3972. doi:10.1097/MD.0000000000003972. PMCΒ 4998335. PMIDΒ 27336897.
- β Hartwig MG, D’Amico TA (June 2010). “Thoracoscopic lobectomy: the gold standard for early-stage lung cancer?”. Ann. Thorac. Surg. 89 (6): S2098β101. doi:10.1016/j.athoracsur.2010.02.102. PMIDΒ 20493989.
- β Ochiai R (2015). “Mechanical ventilation of acute respiratory distress syndrome”. J Intensive Care. 3 (1): 25. doi:10.1186/s40560-015-0091-6. PMCΒ 4456061. PMIDΒ 26045965.
- β BΔlohlΓ‘vek J, Dytrych V, Linhart A (2013). “Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism”. Exp Clin Cardiol. 18 (2): 129β38. PMCΒ 3718593. PMIDΒ 23940438.
- β Khurshid I, Downie GH (2002). “Pulmonary arteriovenous malformation”. Postgrad Med J. 78 (918): 191β7. PMCΒ 1742331. PMIDΒ 11930021.
- β Doshi HM, Robinson S, Chalhoub T, Jack S, Denison A, Gibson G (2009). “Massive spontaneous hemothorax during the immediate postpartum period”. Tex Heart Inst J. 36 (3): 247β9. PMCΒ 2696501. PMIDΒ 19568398.
- β Chanatry BJ (1992). “Acute hemothorax owing to pulmonary arteriovenous malformation in pregnancy”. Anesth. Analg. 74 (4): 613β5. PMIDΒ 1554132.
- β Hoeper MM, Ghofrani HA, GrΓΌnig E, Klose H, Olschewski H, Rosenkranz S (2017). “Pulmonary Hypertension”. Dtsch Arztebl Int. 114 (5): 73β84. doi:10.3238/arztebl.2017.0073. PMCΒ 5331483. PMIDΒ 28241922.
- β Pettiford BL, Luketich JD, Landreneau RJ (February 2007). “The management of flail chest”. Thorac Surg Clin. 17 (1): 25β33. doi:10.1016/j.thorsurg.2007.02.005. PMIDΒ 17650694.
- β Luh SP (2010). “Review: Diagnosis and treatment of primary spontaneous pneumothorax”. J Zhejiang Univ Sci B. 11 (10): 735β44. doi:10.1631/jzus.B1000131. PMCΒ 2950234. PMIDΒ 20872980.
- β Macris MP, Ott DA, Cooley DA (1992). “Complete atrioventricular canal defect: surgical considerations”. Tex Heart Inst J. 19 (3): 239β43. PMCΒ 326195. PMIDΒ 15227445.
- β Safi LM, Liberthson RR, Bhatt A (September 2016). “Current Management of Ebstein’s Anomaly in the Adult”. Curr Treat Options Cardiovasc Med. 18 (9): 56. doi:10.1007/s11936-016-0478-2. PMIDΒ 27439413.
- β Bailliard F, Anderson RH (2009). “Tetralogy of Fallot”. Orphanet J Rare Dis. 4: 2. doi:10.1186/1750-1172-4-2. PMCΒ 2651859. PMIDΒ 19144126.
- β Yoo BW, Park HK (2013). “Pulmonary stenosis and pulmonary regurgitation: both ends of the spectrum in residual hemodynamic impairment after tetralogy of Fallot repair”. Korean J Pediatr. 56 (6): 235β41. doi:10.3345/kjp.2013.56.6.235. PMCΒ 3693041. PMIDΒ 23807889.
- β Stein P (March 2007). “Total anomalous pulmonary venous connection”. AORN J. 85 (3): 509β20, quiz 521β4. doi:10.1016/S0001-2092(07)60123-9. PMIDΒ 17352891.
- β Martins P, Castela E (2008). “Transposition of the great arteries”. Orphanet J Rare Dis. 3: 27. doi:10.1186/1750-1172-3-27. PMCΒ 2577629. PMIDΒ 18851735.
- β Van Praagh R (1987). “Truncus arteriosus: what is it really and how should it be classified?”. Eur J Cardiothorac Surg. 1 (2): 65β70. PMIDΒ 2856609.
- β “Patent Ductus Arteriosus – National Library of Medicine – PubMed Health”.
- β Inamdar AA, Inamdar AC (2016). “Heart Failure: Diagnosis, Management and Utilization”. J Clin Med. 5 (7). doi:10.3390/jcm5070062. PMCΒ 4961993. PMIDΒ 27367736.
- β Maganti K, Rigolin VH, Sarano ME, Bonow RO (2010). “Valvular heart disease: diagnosis and management”. Mayo Clin Proc. 85 (5): 483β500. doi:10.4065/mcp.2009.0706. PMCΒ 2861980. PMIDΒ 20435842.
- β “Myocardial Infarction (Heart Attack): Symptoms – National Library of Medicine – PubMed Health”.
- β Werdan K, RuΓ M, Buerke M, Delle-Karth G, Geppert A, SchΓΆndube FA; et al. (2012). “Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline”. Dtsch Arztebl Int. 109 (19): 343β51. doi:10.3238/arztebl.2012.0343. PMCΒ 3364528. PMIDΒ 22675405.
- β Marian AJ, Braunwald E (September 2017). “Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy”. Circ. Res. 121 (7): 749β770. doi:10.1161/CIRCRESAHA.117.311059. PMIDΒ 28912181.
- β Hoffmeier A, Sindermann JR, Scheld HH, Martens S (2014). “Cardiac tumors–diagnosis and surgical treatment”. Dtsch Arztebl Int. 111 (12): 205β11. doi:10.3238/arztebl.2014.0205. PMCΒ 3983698. PMIDΒ 24717305.
- β Kannan M, Vijayanand G (2010). “Mitral stenosis and pregnancy: Current concepts in anaesthetic practice”. Indian J Anaesth. 54 (5): 439β44. doi:10.4103/0019-5049.71043. PMCΒ 2991654. PMIDΒ 21189882.
- β Das S, Maiti A (2013). “Acrocyanosis: an overview”. Indian J Dermatol. 58 (6): 417β20. doi:10.4103/0019-5154.119946. PMCΒ 3827510. PMIDΒ 24249890.
- β Lyaker MR, Tulman DB, Dimitrova GT, Pin RH, Papadimos TJ (2013). “Arterial embolism”. Int J Crit Illn Inj Sci. 3 (1): 77β87. doi:10.4103/2229-5151.109429. PMCΒ 3665125. PMIDΒ 23724391.
- β Block JA, Sequeira W (June 2001). “Raynaud’s phenomenon”. Lancet. 357 (9273): 2042β8. doi:10.1016/S0140-6736(00)05118-7. PMIDΒ 11438158.
- β Cohen R, Mena D, Carbajal-Mendoza R, Matos N, Karki N (2008). “Superior vena cava syndrome: A medical emergency?”. Int J Angiol. 17 (1): 43β6. PMCΒ 2728369. PMIDΒ 22477372.
- β Fan CM (2005). “Venous pathophysiology”. Semin Intervent Radiol. 22 (3): 157β61. doi:10.1055/s-2005-921949. PMCΒ 3036287. PMIDΒ 21326688.
- β Ashurst J, Wasson M (July 2011). “Methemoglobinemia: a systematic review of the pathophysiology, detection, and treatment”. Del Med J. 83 (7): 203β8. PMIDΒ 21954509.
- β Spivak JL (February 2002). “The optimal management of polycythaemia vera”. Br. J. Haematol. 116 (2): 243β54. PMIDΒ 11841424.
- β Goldman RD (2015). “Breath-holding spells in infants”. Can Fam Physician. 61 (2): 149β50. PMCΒ 4325862. PMIDΒ 25676645.
- β Goldenberg MM (2010). “Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment”. P T. 35 (7): 392β415. PMCΒ 2912003. PMIDΒ 20689626.
- β Brown EN, Lydic R, Schiff ND (2010). “General anesthesia, sleep, and coma”. N Engl J Med. 363 (27): 2638β50. doi:10.1056/NEJMra0808281. PMCΒ 3162622. PMIDΒ 21190458.
- β McAllister TW (2011). “Neurobiological consequences of traumatic brain injury”. Dialogues Clin Neurosci. 13 (3): 287β300. PMCΒ 3182015. PMIDΒ 22033563.
- β Parati G, Agostoni P, Basnyat B, Bilo G, Brugger H, Coca A, Festi L, Giardini G, Lironcurti A, Luks AM, Maggiorini M, Modesti PA, Swenson ER, Williams B, BΓ€rtsch P, Torlasco C (January 2018). “Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions”. Eur. Heart J. doi:10.1093/eurheartj/ehx720. PMIDΒ 29340578.
- β Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL (2016). “Sepsis and septic shock”. Nat Rev Dis Primers. 2: 16045. doi:10.1038/nrdp.2016.45. PMCΒ 5538252. PMIDΒ 28117397.
- β Rehberg S, Maybauer MO, Enkhbaatar P, Maybauer DM, Yamamoto Y, Traber DL (2009). “Pathophysiology, management and treatment of smoke inhalation injury”. Expert Rev Respir Med. 3 (3): 283β297. doi:10.1586/ERS.09.21. PMCΒ 2722076. PMIDΒ 20161170.
- β Marriott, Bernadette (1996). Nutritional needs in cold and in high-altitude environmentsΒ : applications for military personnel in field operations. Washington, D.C: National Academy Press. ISBNΒ 0-309-05484-2.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Eiman Ghaffarpasand, M.D. [2], Fahimeh Shojaei, M.D., Priyamvada Singh, M.B.B.S. [3], Keri Shafer, M.D. [4]; Kristin Feeney, B.S. [5]
Epidemiology and Demographics
Overview
Tetralogy of Fallot occurs in approximately 30 to 60 per 100,000 births. Tetralogy of Fallot represents 5-7% of congenital heart defects. The majority of cases are thought to be sporadic and are not familial. Tetralogy of Fallot occurs slightly more often in males than in females.
Epidemiology and Demographics
Prevalance
- Tetralogy of Fallot occurs in approximately 30 to 60 per 100,000 births.[1]
- It represents 5-7% of congenital heart defects.
Incidence
- The majority of cases are thought to be sporadic and are not familial.
- The incidence in siblings is 1% to 5%.
Gender
References
- β Goldmuntz, Elizabeth (2001). “THE EPIDEMIOLOGY AND GENETICS OF CONGENITAL HEART DISEASE”. Clinics in Perinatology. 28 (1): 1β10. doi:10.1016/S0095-5108(05)70067-1. ISSNΒ 0095-5108.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2], Keri Shafer, M.D. [3]; Kristin Feeney, B.S. [4]
Risk Factors
Overview
Common risk factors in the development of tetralogy of Fallot include: Alcoholism in the mother, diabetes, and pregnancy after the age of 40.
Risk Factors
Common Risk Factors
- Common risk factors in the development of tetralogy of Fallot include:Patients with tetralogy of Fallot may have a positive history of:[1][2]
- Alcoholism in the mother
- Diabetes in mother
- Pregnancy after the age of 40
Less Common Risk Factors
- Less common risk factors in the development of tetralogy of Fallot include:
References
- β “Congenital Malformations in Infants of Diabetic Mothers”. QJM: An International Journal of Medicine. 1976. doi:10.1093/oxfordjournals.qjmed.a067465. ISSNΒ 1460-2393.
- β Loser, H; Majewski, F (1977). “Type and frequency of cardiac defects in embryofetal alcohol syndrome. Report of 16 cases”. Heart. 39 (12): 1374β1379. doi:10.1136/hrt.39.12.1374. ISSNΒ 1355-6037.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Screening
Overview
According to the Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association, screening for tetralogy of Fallot by pulse oxymetry is recommended for all newborns.
Screening
According to the Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association, screening for tetralogy of Fallot by pulse oxymetry is recommended for all newborns:[1]

References
- β Wong, Kenny K.; Fournier, Anne; Fruitman, Deborah S.; Graves, Lisa; Human, Derek G.; Narvey, Michael; Russell, Jennifer L. (2017). “Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection of Critical Congenital Heart Disease”. Canadian Journal of Cardiology. 33 (2): 199β208. doi:10.1016/j.cjca.2016.10.006. ISSNΒ 0828-282X.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Natural History, Complications and Prognosis
Overview
The prognosis of patients with repaired tetralogy of Fallot has improved over the years and these patients now have the potential to lead normal lives. As these patients grow, there may be leakage of the repaired pulmonic valve. There may be a persistent risk of sudden cardiac death.
Natural History
- If left untreated, the natural history of tetralogy of Fallot results in progressive right ventricular hypertrophy and right ventricular dilatation due to the increased resistance to flow into the pulmonary circuit.
- The dilated cardiomyopathy progresses to right heart failure, usually with accompanying left heart failure.
Complications
Common complications of tetralogy of fallot include:[1][2]
- Delayed growth and development
- Irregular heart rhythms (arrhythmias)
- Seizures as a result of hypoxia
- Stroke and embolic complications such as a brain abscess
- Pulmonary embolism
- Sudden cardiac death: The worse the right ventricle dysfunction, the worse the risk for ventricular tachycardia and sudden death.
- Bacterial endocarditis
- Reoperation for pulmonary stenosis
Prognosis
Unrepaired Tetralogy of Fallot
The survival for unrepaired tetralogy of Fallot is as follows:[3]
- 75% at one year
- 70% at two years
- 60% at four years
- 50% at six years
- 30% at ten years
- 10% at twenty years
- 5% at forty years
- If pulmonary atresia is present as well, survival is even poorer with only 50% of patients surviving to one year, and only 8% of patients surviving to 10 years.
Repaired Tetralogy of Fallot
- Patients with repaired tetralogy of Fallot now have the potential to lead normal lives with continued excellent cardiac function.
- Most survivors are in NYHA Class I heart failure.
- Some patients have more pronounced symptoms with exertion.[4][5]
- Current techniques for total surgical repair greatly improve the hemodynamic function of the heart with tetralogy of Fallot but do not provide a lifetime correction of the defect.
- Ninety percent of patients with total repair as infants develop a progressively leaky pulmonary valve (pulmonic insufficiency as the heart grows to its adult size. Patients also may have some degree of residual right ventricular outflow obstruction and damage to the conduction system of the heart from surgical corrections, causing conduction abnormalities on the EKG and/or arrhythmias.
- Tetralogy of Fallot patients are at risk for development of heart failure. Therefore, lifetime follow-up care by an adult congenital cardiologist is recommended to assess and monitor these risks and to recommend treatment, such as interventional procedures or re-operation, if it becomes necessary.
- Tetralogy of Fallot patients are at risk for sudden cardiac death with a 1% to 5% lifetime incidence. Risk factors for sudden cardiac death include:
- Older age at repair
- Male sex
- Advanced NY heart association class
- Repair via atriotomy
- Two major electrocardiographic risk factors include complete heart block beyond the third post operative day and QRS duration > 18 milliseconds, and rapid development of QRS prolongation in the first 6 months after repair.
- There is limited data regarding the benefit of automatic implantable cardiac defibrillator (AICD) implantation in these patients.
- Antibiotic prophylaxis is indicated during dental treatment in order to prevent infective endocarditis.
References
- β Cheung, Michael M.H.; Konstantinov, Igor E.; Redington, Andrew N. (2005). “Late Complications of Repair of Tetralogy of Fallot and Indications for Pulmonary Valve Replacement”. Seminars in Thoracic and Cardiovascular Surgery. 17 (2): 155β159. doi:10.1053/j.semtcvs.2005.02.006. ISSNΒ 1043-0679.
- β Gregg, David; Foster, Elyse (2007). “Pulmonary insufficiency is the nexus of late complications in tetralogy of Fallot”. Current Cardiology Reports. 9 (4): 315β322. doi:10.1007/BF02938380. ISSNΒ 1523-3782.
- β Bertranou EG, Blackstone EH, Hazelrig JB, Turner ME, Kirklin JW (September 1978). “Life expectancy without surgery in tetralogy of Fallot”. Am. J. Cardiol. 42 (3): 458β66. doi:10.1016/0002-9149(78)90941-4. PMIDΒ 685856.
- β Park CS, Lee JR, Lim HG, Kim WH, Kim YJ (September 2010). “The long-term result of total repair for tetralogy of Fallot”. Eur J Cardiothorac Surg. 38 (3): 311β7. doi:10.1016/j.ejcts.2010.02.030. PMIDΒ 20346688.
- β Lindberg HL, Saatvedt K, Seem E, Hoel T, Birkeland S (September 2011). “Single-center 50 years’ experience with surgical management of tetralogy of Fallot”. Eur J Cardiothorac Surg. 40 (3): 538β42. doi:10.1016/j.ejcts.2010.12.065. PMIDΒ 21354809.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Fahimeh Shojaei, M.D., Priyamvada Singh, M.B.B.S. [2]; Kristin Feeney, B.S. [3]
Diagnosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Interventions | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Fahimeh Shojaei, M.D., Priyamvada Singh, M.B.B.S. [2], Kristin Feeney, B.S. [3]

